Literature DB >> 7083096

Proportional analysis of respiratory cells obtained by bronchoalveolar lavage.

A C Braude, D W Chamberlain, A S Rebuck.   

Abstract

Bronchoalveolar lavage was performed during fibreoptic bronchoscopy in 17 patients with biopsy-proven interstitial lung disease and in 12 control subjects who had focal lesions in the lung. The volume of fluid recovered was unrelated to disease activity or diagnosis. In the control subjects alveolar macrophages represented over 95% of the lavaged cells. The proportion of lymphocytes in the lavaged cells enabled a natural division of the diffuse interstitial lung diseases into two categories: active sarcoidosis, indicated by a large proportion of lymphocytes but a normal proportion of polymorphonuclear leukocytes; and idiopathic pulmonary fibrosis and asbestosis, indicated by a normal proportion of lymphocytes but a variable proportion of polymorphonuclear leukocytes. Bronchoalveolar lavage is a safe and well tolerated method for evaluating the role of alveolitis in diffuse interstitial lung disease through the sampling of respiratory alveolar cells.

Entities:  

Mesh:

Year:  1982        PMID: 7083096      PMCID: PMC1863127     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  Classification of bronchial lymphocytes from nonsmokers and smokers.

Authors:  G A Warr; R R Martin; C L Holleman; B S Criswell
Journal:  Am Rev Respir Dis       Date:  1976-01

2.  Quantitation of inflammatory activity in interstitial pneumonitis by bronchofiberscopic pulmonary lavage.

Authors:  G S Davis; A R Brody; J N Landis; W G Graham; J E Craighead; G M Green
Journal:  Chest       Date:  1976-02       Impact factor: 9.410

3.  Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood.

Authors:  R P Daniele; J H Dauber; M D Altose; D T Rowlands; D J Gorenberg
Journal:  Am Rev Respir Dis       Date:  1977-12

4.  Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.

Authors:  H Y Reynolds; H H Newball
Journal:  J Lab Clin Med       Date:  1974-10

5.  Bronchopulmonary lavage in man.

Authors:  J Ramirez; R F Kieffer; W C Ball
Journal:  Ann Intern Med       Date:  1965-11       Impact factor: 25.391

6.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Bronchoalveolar lavage for the preparation of free lung cells: technique and complications.

Authors:  P Cole; C Turton; H Lanyon; J Collins
Journal:  Br J Dis Chest       Date:  1980-07

8.  Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers.

Authors:  R B Low; G S Davis; M S Giancola
Journal:  Am Rev Respir Dis       Date:  1978-11

9.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

10.  Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.

Authors:  J O Harris; E W Swenson; J E Johnson
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

View more
  5 in total

Review 1.  Assessment of drug disposition in the lung.

Authors:  A S Rebuck; A C Braude
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

2.  Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.

Authors:  F L Liu; R D Cohen; E Downar; J W Butany; J D Edelson; A S Rebuck
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

3.  Tuberous sclerosis with pulmonary involvement.

Authors:  B A Liberman; D W Chamberlain; R S Goldstein
Journal:  Can Med Assoc J       Date:  1984-02-01       Impact factor: 8.262

4.  Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?

Authors:  R D Cohen; P S Bunting; H O Meindok; D W Chamberlain; A S Rebuck
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

5.  A sequential broncho-alveolar washing in non-anaesthetized normal bovines: method and preliminary results.

Authors:  M Viso; M R el Jaraki; J Espinasse; A L Parodi; J F Dedieu
Journal:  Vet Res Commun       Date:  1985-07       Impact factor: 2.459

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.